{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-248678","form_type":"8-K","ticker":"NRIX","cik":"0001549595","company_name":"Nurix Therapeutics, Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.759442+00:00","generated_at":"2026-05-30T07:25:12.025168+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nurix Therapeutics files $300M at-the-market stock offering via Piper Sandler","bullets":["Amendment No.2 to Equity Distribution Agreement authorizes up to $300M aggregate gross offering price of common stock in ATM offerings.","Piper Sandler receives up to 3.0% sales commission on gross proceeds; expenses reimbursed up to $50K for this amendment.","Offering uses existing automatic shelf registration statement (File No. 333-280117) and prospectus supplement dated Oct 31, 2024.","No specific use of proceeds disclosed in the filing; proceeds will be net of commissions and expenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-248678","json":"https://secwatch.observer/filing/0001193125-24-248678.json","markdown":"https://secwatch.observer/filing/0001193125-24-248678.md","text":"https://secwatch.observer/filing/0001193125-24-248678.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549595/000119312524248678/0001193125-24-248678-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549595/000119312524248678/d904494d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:25:12.025168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}